Ely Benaim
2016
In 2016, Ely Benaim earned a total compensation of $723.8K as Chief Medical Officer at Rexahn Pharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $120,000 |
| Option Awards | $114,791 |
| Salary | $375,000 |
| Other | $13,983 |
| Total | $723,774 |
Benaim received $375K in salary, accounting for 52% of the total pay in 2016.
Benaim also received $100K in bonus, $120K in non-equity incentive plan, $114.8K in option awards and $14K in other compensation.
Rankings
In 2016, Ely Benaim's compensation ranked 9,735th out of 14,075 executives tracked by ExecPay. In other words, Benaim earned more than 30.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,735 out of 14,075 | 31st |
Division Manufacturing | 3,766 out of 5,489 | 31st |
Major group Chemicals And Allied Products | 1,312 out of 1,895 | 31st |
Industry group Drugs | 1,043 out of 1,538 | 32nd |
Industry Pharmaceutical Preparations | 820 out of 1,176 | 30th |
Source: SEC filing on February 24, 2017.
Benaim's colleagues
We found three more compensation records of executives who worked with Ely Benaim at Rexahn Pharmaceuticals in 2016.